E-mail:gzliang@cqu.edu.cn    Tel: (86)2365102507

List of peptide properties
DFBP ID - DFBPACEI0575(ACE-inhibitory peptide)
DFBP ID DFBPACEI0575
Peptide sequence TTMPLW
Type Native peptide
Peptide/Function name ACE-inhibitory peptide, CEIαC6 [4]
Function-activity relationship
Main bioactivity ACE-inhibitory activity
Otheir bioactivity Antihypertensive activity [D1], DPP IV-inhibitory activity [D2], Immunomodulatory activity [D3], Opioid activity [D4], Multifunctional activity [D5]
Calculated physicochemical properties
Three-letter amino acid Thr-Thr-Met-Pro-Leu-Trp
Single-letter amino acid TTMPLW
Peptide length 6
Peptide mass
Experimental mass Theoretical mass
748 Da 747.90 Da c
Net charge 0.00 c
Isoelectric point (pI) 5.97 c
IC50 51 uM, 12 uM [2], 16 μM [4]
pIC50 -1.708, -1.079, -1.204
GRAVY 0.3000 c
Hydrophilic residue ratio 66.67% c
Peptide calculator
To calculate the physicochemical properties of bioactive peptide.
Peptide source & Food-borne protein(s) search
Classification Animal
Organism/Source Milk protein, Ficus carica [1]
Precursor protein αs1-Casein
Residue position

f(194-199)

Precursor protein(s) search
Link-research
There are no literature reports on the discovery of this sequence in other food-source proteins.
Biological/Functional activity & target protein
ACE-inhibitory activity

(1) The peptide exhibited potent Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) inhibitory activity with an IC50 value of 51 μM.
(2) The peptide showed potent ACE-inhibitory activity with an IC50 value of 12 uM [2].
(3) The peptide showed potent ACE-inhibitory activity with an IC50 value of 16 uM [4].

Specific target protein(s) Specific Target Protein(s):
Angiotensin-converting enzyme
Taste properties & Structure
Bitterness
Literature report N.D
Bitter prediction tools Bitter taste prediction
SMILES N[C@@]([H])([C@]([H])(O)C)C(=O)N[C@@]([H])([C@]([H])(O)C)C(=O)N[C@@]([H])(CCSC)C(=O)N1[C@@]([H])(CCC1)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(CC(=CN2)C1=C2C=CC=C1)C(=O)O
Preparation method
Mode of preparation

Fermentation and enzymatic hydrolysis

Enzyme(s)/starter culture

Whey and casein proteins were fermented with lactic acid bacteria and hydrolysed subsequently by digestive enzymes (pepsin and trypsin).

Stability & Cytotoxicity
Peptide stability
Literature report: N.D
EHP-Tool: Enzymatic Hydrolysis Prediction Tool (EHP-Tool)
Peptide cytotoxicity
Literature report: N.D
Prediction: ToxinPred
Additional information
Additional information N.D
Database cross-references
DFBP
[D1] DFBPANHY0140, DFBPANHY0974
[D2] DFBPDPIV0188
[D3] DFBPIMMU0029
[D4] DFBPOPIO0068
[D5] DFBPMUFU0137
BIOPEP-UWM [D6] 3127, 3530, 8172, 9619
APD [D7] -
BioPepDB [D8] -
MBPDB [D9] -
Reference(s)
Primary literature Pihlanto-Leppälä, A., Rokka, T., Korhonen, H. Angiotensin I Converting Enzyme Inhibitory Peptides Derived from Bovine Milk Proteins. International Dairy Journal. 1998, 8, 325-31.
Other literature(s)

[1] Maruyama S, Miyoshi S, Tanaka H. Angiotensin I-Converting Enzyme Inhibitors Derived from Ficus carica[J]. Journal of the Agricultural Chemical Society of Japan, 1989, 53(10):2763-2767.
[2] Murray B A, Fitzgerald R J. Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production[J]. Current Pharmaceutical Design, 2007, 13(8):-.
[3] Bösze Z. Bioactive Components of Milk[M]. Springer New York, 2008.
[4] Maruyama S,  Mitachi H,  Awaya J, et al. Angiotensin I-Converting Enzyme Inhibitory Activity of the C-Terminal Hexapeptide of αs1-Casein[J]. Agricultural and biological chemistry, 1987, 51(9):2557-2561.
[5] Tauzin, J., L. Miclo, and J.L. Gaillard, Angiotensin-I-converting enzyme inhibitory peptides from tryptic hydrolysate of bovine alphaS2-casein. FEBS Lett, 2002. 531(2): p. 369-74.
[6] De Gobba, C., G. Tompa, and J. Otte, Bioactive peptides from caseins released by cold active proteolytic enzymes from Arsukibacterium ikkense. Food Chem, 2014. 165: p. 205-15.

PubDate 1998
Copyright © 2020. Record / license number: Chongqing ICP No. 2000214